A Randomized, Active- and Placebo-Controlled Study of the Efficacy and Safety of Different Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects with Androgenetic Alopecia

    Walter Gubelin Harcha, Julia Barboza Martínez, Tsen-Fang Tsai, Kensei Katsuoka, Makoto Kawashima, Ryoji Tsuboi, Allison Barnes, Geraldine Ferron-Brady, Dushendra J. Chetty
    Image of study
    TLDR Dutasteride 0.5 mg works better than finasteride and placebo for increasing hair in men with hair loss.
    This study compared the efficacy and safety of different doses of dutasteride, finasteride, and placebo in treating male subjects with androgenetic alopecia. The results showed that dutasteride 0.5 mg was superior to finasteride and placebo in increasing hair count and width after 24 weeks of treatment. Both dutasteride and finasteride were well-tolerated, with similar tolerability data reported for both active treatments. The study concluded that dutasteride is an effective and safe treatment for male subjects with androgenetic alopecia.
    Discuss this study in the Community →

    Cited in this study

    14 / 14 results


    8 / 8 results